-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Parkinson’s
The Michael J. Fox Foundation Launches New Funding Opportunities
The Michael J. Fox Foundation (MJFF) is committed to sharing the risk of drug development with researchers from academia and industry alike in order to keep promising research moving forward along the Parkinson’s disease (PD) drug pipeline. To date, MJFF has funded over $300 million in research, $83 million of which has been awarded to more than 180 unique, industry-led projects. On February 20, MJFF launched nine funding programs, three of which are new to Read More >
Some ABCs of PAGs
A lot of people, and especially those who have attended BIO events (such as the BIO CEO & Investor Conference, BIO Investor Forum, and the BIO Business Forum) are familiar with the names Michael J. Fox Foundation, FasterCures, ALS Therapy Development Institute, JDRF, and other non-profit Patient Advocacy Groups, or “PAG’s”. In case you missed them, two blog posts came up from the Michael J. Fox Foundation and FasterCures that we wanted to share. They Read More >
MJFF’s Innovative, New Funding Program Addresses the Entire Therapeutic Pipeline
To date, the Michael J. Fox Foundation for Parkinson’s Research has funded over $297 million in research, $77 million of which has been awarded to more than 160 unique, industry-led projects. In June 2012, MJFF announced its newest funding mechanism, the Therapeutic Pipeline Program (TPP), which combines MJFF’s previous Therapeutics Development Initiative (TDI), Repositioning Drugs for PD, and Clinical Intervention Awards (CIA) programs into a single, streamlined funding opportunity. Open to both industry and academic Read More >
Fox Trial Finder and You: Use It to Recruit for Your Trials or to Get Involved Yourself!
From The Michael J. Fox Foundation for Parkinson’s Research The Michael J. Fox Foundation has launched Fox Trial Finder, a new Web tool that uses state-of-the art technology to connect potential study volunteers with the coordinators of clinical studies that need someone with their specific medical history. The goal is to benefit both study sponsors and patients by getting people into clinical trials and studies faster — speeding the development of new treatments and ultimately a Read More >
BIO CEO Company Snapshot: NuPathe Inc.
The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & Investor Conference, taking place in New York City this February. The companies that will be profiled in these snapshots will all be presenting at the event, and we hope this provides the opportunity to learn more about them, and catch up on what’s new. For our first Snapshot for the BIO CEO event, we’ve spoken with NuPathe Inc. about their Read More >
